Lanean...
Unplanned discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia
This study was conducted to investigate the outcomes of patients with chronic myeloid leukemia (CML) who discontinued tyrosine kinase inhibitor (TKI) treatment. A single-center retrospective analysis was performed, including 46 chronic-phase (CP) CML patients who achieved complete molecular response...
Gorde:
| Argitaratua izan da: | Mol Clin Oncol |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
D.A. Spandidos
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4727029/ https://ncbi.nlm.nih.gov/pubmed/26870364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.653 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|